Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.979 USD | +2.28% | -4.82% | -41.98% |
Financials (USD)
Sales 2024 * | 6.27M | Sales 2025 * | 18.26M | Capitalization | 21.05M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -3M | EV / Sales 2024 * | 3.36 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.15 x |
P/E ratio 2024 * |
-2.8
x | P/E ratio 2025 * |
-1.97
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.4% |
Latest transcript on Evaxion Biotech A/S
1 day | +0.39% | ||
1 week | -4.82% | ||
Current month | -4.59% | ||
1 month | +10.52% | ||
3 months | -6.38% | ||
6 months | -65.10% | ||
Current year | -41.98% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Mattsson
FOU | Founder | - | 08-08-10 |
Niels Møller
FOU | Founder | 46 | 08-08-10 |
Chief Executive Officer | 52 | 23-08-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 54 | 17-12-31 | |
Lars Holtug
BRD | Director/Board Member | 66 | 21-05-24 |
Marianne Søgaard
CHM | Chairman | 56 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 3.979 | +2.28% | 12 217 |
24-05-02 | 3.89 | -0.51% | 7,567 |
24-05-01 | 3.91 | -6.24% | 3,741 |
24-04-30 | 4.17 | -2.80% | 9,644 |
24-04-29 | 4.29 | +2.63% | 16,494 |
Delayed Quote Nasdaq, May 03, 2024 at 12:15 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.98% | 21.05M | |
+23.60% | 48.09B | |
+46.90% | 40.62B | |
-2.55% | 40.43B | |
-6.20% | 28.36B | |
+8.37% | 24.89B | |
-20.07% | 19.01B | |
+28.93% | 12.09B | |
-0.12% | 11.88B | |
-0.91% | 11.8B |
- Stock Market
- Equities
- EVAX Stock